-
1 Comment
Wright Medical Group N.V is currently in a long term uptrend where the price is trading 0.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.7.
Wright Medical Group N.V's total revenue rose by 5.1% to $223M since the same quarter in the previous year.
Its net income has increased by 55.0% to $-20M since the same quarter in the previous year.
Finally, its free cash flow grew by 2262.8% to $8M since the same quarter in the previous year.
Based on the above factors, Wright Medical Group N.V gets an overall score of 5/5.
CurrencyCode | USD |
---|---|
ISIN | USN966171183 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Devices |
Market Cap | 4B |
---|---|
PE Ratio | None |
Target Price | 30.8 |
Dividend Yield | 0.0% |
Beta | 0.64 |
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands. As of November 10, 2020, Wright Medical Group N.V. operates as a subsidiary of Stryker B.V.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for WMGI using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025